One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...

Rutgers Health, in partnership with the New Jersey Department of Labor and Workforce Development (NJDOL), has launched the ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid​ medications like Vicodin and OxyContin.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

“But it is a slam dunk in that it’s a very different pathway and mechanism of action ... making it many times more expensive than comparable opioids, which are often available as generics ...

The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...